BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen A, Santana AL, Doudican N, Roudiani N, Laursen K, Therrien JP, Lee J, Felsen D, Carucci JA. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS One 2020;15:e0241551. [PMID: 33227008 DOI: 10.1371/journal.pone.0241551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang S, Fang H, Chen W, Yan Y. Expression of Cancer-testis Antigens in Adenoid Cystic Carcinoma of the Salivary Glands Correlates with Clinical Outcomes. J hard tissue biol 2021;30:283-90. [DOI: 10.2485/jhtb.30.283] [Reference Citation Analysis]
2 Li S, Shi X, Li J, Zhou X. Pathogenicity of the MAGE family. Oncol Lett 2021;22:844. [PMID: 34733362 DOI: 10.3892/ol.2021.13105] [Reference Citation Analysis]
3 Schäfer P, Paraschiakos T, Windhorst S. Oncogenic activity and cellular functionality of melanoma associated antigen A3. Biochem Pharmacol 2021;192:114700. [PMID: 34303709 DOI: 10.1016/j.bcp.2021.114700] [Reference Citation Analysis]